Full Course Description

2-Day: Emergency Nursing Conference: COVID’s Lasting Implications on Bedside Practice

Do you remember the feeling you had when you received that very first COVID admission? The anxiety you felt when you were told you were deploying to work in the COVID unit?

I remember those early days of the pandemic very well. I imagine the experiences will be etched in all of our memories forever. These patients have been critically ill, some have died. They didn’t look that sick initially, and suddenly they deteriorated within hours.

Do you wonder if you should have done something different in caring for these patients? Would the outcome possibly have been different?

Now, more than ever, nurses working in high acuity areas (emergency departments, critical care, progressive care) need to rely on our credible knowledge base, expert skills, and our compassion to safeguard patient outcomes for critically ill patients in this new era of clinical practice. Nursing has been confronted with heavy workloads, fast changes in the workplace, ambiguity, fatigue, and a new disease process with a myriad of systemic complications that were unfamiliar to us.

Purchase now! I will provide you with confidence to rapidly assess your sickest patients, knowledge to implement COVID-19 evidence-based practice changes, and insight into what normalization will look like in healthcare. My training is filled with unforgettable patient case studies, reinforced with helpful mnemonics, and real-world clinical solutions. I guarantee you will experience dramatic practice changes when you work your next shift!

Robin Gilbert, MSN, RN, CEN, CPEN
and the PESI Healthcare Team

Program Information

Objectives

  1. Evaluate the unprecedented organizational responses to COVID-19 challenges.
  2. Appraise clinical staff preparedness after working in a respiratory pandemic environment.
  3. Propose why prone positioning benefits respiratory complications associated with COVID-19.
  4. Plan to use appropriate modes of ventilator support, invasive and non-invasive, for patients with respiratory failure secondary to COVID-19 infection.
  5. Distinguish the cardiopulmonary interactions underlying the risks, benefits, and applications of ventilator support for respiratory failure secondary to COVID-19 infection.
  6. Construct policy changes for cardiac arrest response.
  7. Evaluate the factors of intravascular coagulation contributing to mortality in COVID-19 patients.
  8. Determine best practices in providing quality and safe nursing care for critically ill patients.
  9. Assess how diagnoses may mimic COVID-19.
  10. Distinguish clinical manifestations of COVID-19 disease in multiple organ systems.
  11. Assess long-term effects of COVID-19 which occur after the acute phase.
  12. Appraise how the lessons learned from the first phase of COVID-19 influenced current assessment & treatment.
  13. Differentiate medication uses specifically for COVID-19 patients.
  14. Determine myths vs. medications which have been proven effective in COVID-19 treatment.

Outline

Day 1
Session 1: COVID-19 & The Practice Impact

  • Responding to a rapid response or code blue: Then & now
  • PPE changes: Surgical masks, N95, PAPR, goggles, face shields
  • Surge in demand for critical care nurses: Education needed for deploying nurses
  • Hidden challenges
Session 2: Hypoxia, ARDS, and other Respiratory Complications
  • Respiratory strategies
    • High flow nasal cannula
    • NPPV
    • Mechanical ventilation
    • ECMO
  • Acute respiratory failure
  • Asthma
  • Pneumothorax, pneumomediastinum, pneumopericardium
  • COPD
  • ARDS
  • Pulmonary embolism
  • Prone positioning
  • Pharmacological challenges
Session 3: Cardiovascular Considerations
  • Hemodynamics
  • Rhythm recognition
  • Arrhythmia and conduction disease with COVID-19
  • Pericarditis
  • Endocarditis
  • Myocarditis
  • Atrial fibrillation
  • Heart failure
  • Cardiac tamponade
  • Cardiogenic shock and ventricular septal rupture
Day 2
Session 1: Neurological: Cerebrovascular Complications & Coagulopathies
  • ICP
  • Stroke
  • Seizures
  • Pathophysiology of arterial & venous thrombosis in COVID-19
  • Coagulopathies & guidelines on anticoagulation
  • Monitoring the brain from the bedside
Session 2: COVID-19 & the Collision with other Diagnoses
  • Diabetes
  • End stage kidney disease
  • GI disease
  • Labor, delivery, post-partem
Session 3: Post COVID Syndrome Concerns
  • Fever, anorexia, myalgia, headache
  • Rash, sore throat, face pain
  • Loss of smell and taste
  • Peritonsillar abscess
  • Risk of rehospitalization
  • Long term sequalae of severe COVID-19 infection
Session 4: Pharmacologic Therapy in Critical Care
  • Vasopressors & inotropes
  • Proton pump inhibitors
  • Anticoagulants
  • Sedation & intubation medications
  • Nebulized medications in COVID-19
  • COVID-19 medications/vaccines

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants
  • Respiratory Therapists
  • Physicians

Copyright : 08/25/2021

Risks & Consequences of COVID-19 on Mental Health: A Psychopharmacology Update

Expert Clinician Sonata Bohen, a Psychiatric Nurse Practitioner and NEI Master Psychopharmacologist, knows well the challenges you are facing in practice right now.  You, too, are seeing patients experiencing increasing levels of social isolation, unemployment and financial concerns, domestic abuse and resulting mental health diagnoses, particularly amongst our most vulnerable patient populations.  

As the insidious effects of Covid-19 are taking place all across the country, those physical symptoms must be managed, just as well as we are learning how to.  As if all of that was not challenging enough, there are more and more Covid-19 patient cases where unanticipated interactions with psychotropic medications are taking place, increased incidence of drug induced delirium and for a long list of reasons, mental health needs, in general, are requiring our very careful attention.

There has not been a time of greater responsibility for patients – in terms of both their critical physical and mental health needs.  You must make time to join Sonata as she hits the practical highlights to help guide important decisions you are making for patients during this pandemic.  She knows that we are all in this together…

Program Information

Objectives

  1. Analyze vulnerable populations at greater risk of Covid-19.
  2. Assess for medical disorders in people with mental illness that can cause complications with Covid-19.
  3. Distinguish the consequences of Covid-19 for increased incidence of suicide, domestic violence and child abuse.
  4. Plan how current Covid-19 treatments can have an effect on psychotropic medications.
  5. Evaluate the need for medication adjustments considering the organ/system effected by Covid-19.

Outline

Vulnerable Populations

  • Barriers in access to care
  • Increased risks during this pandemic

Increasing Risk through Social Isolation and Unemployment

  • Domestic violence
  • Suicide
  • Child abuse
  • Food insecurity
  • Substance abuse and the opiate epidemic
  • Worsening physical health

Psychopharmacology: Consequences of Covid-19

  • Organ and systems impacted 
  • Caution in dosing and selection of medications in Covid-19 patients with mental illness
  • Increase of drug induced delirium in patients on respirators with Covid-19
  • Medications used to treat Covid-19  - and possible interactions with psychotrophic medications

Global Connectedness

  • What we can learn from other nations and cultures in this present pandemic
  • How we can all come out as better people from this crisis

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Case Managers
  • Pharmacists
  • Psychiatrists

Copyright : 11/24/2020